Thiazolidinediones News and Research

RSS
Thiazolidinediones are adjunctive therapies for diabetes mellitus (type 2) and related diseases.
Study finds Avandia may increase risk of heart failure

Study finds Avandia may increase risk of heart failure

GlaxoSmithKline response to JAMA article on ICES retrospective analysis

GlaxoSmithKline response to JAMA article on ICES retrospective analysis

Rosiglitazone and Pioglitazone increase risk of congestive heart failure but not the risk of cardiovascular death

Rosiglitazone and Pioglitazone increase risk of congestive heart failure but not the risk of cardiovascular death

Discovery may  lead to new class of diabetes drugs

Discovery may lead to new class of diabetes drugs

Caution urged on use of drugs to raise "good" cholesterol

Caution urged on use of drugs to raise "good" cholesterol

Takeda responds to FDA recommendation on Actos

Takeda responds to FDA recommendation on Actos

Avandia too risky says expert

Avandia too risky says expert

Metformin gets top grade for diabetes

Metformin gets top grade for diabetes

Plant chemical harmine fights diabetes in mice

Plant chemical harmine fights diabetes in mice

Pioglitazone may help slow progression of artery wall thickening

Pioglitazone may help slow progression of artery wall thickening

Thiazolidinediones may reduce cardiovascular risks

Thiazolidinediones may reduce cardiovascular risks

New diabetes drug Januvia works without causing weight gain

New diabetes drug Januvia works without causing weight gain

Alzheimer's disease linked to raised blood sugar levels

Alzheimer's disease linked to raised blood sugar levels

Latest diabetic medications more costly, but users have fewer hospital visits

Latest diabetic medications more costly, but users have fewer hospital visits

Study reveals mechanisms behind Thiazolidinediones used to treat type 2 diabetes

Study reveals mechanisms behind Thiazolidinediones used to treat type 2 diabetes

Scientists have discovered how C-reactive protein is able to access endothelial cells

Scientists have discovered how C-reactive protein is able to access endothelial cells

Insulin resistance drug with anti-inflammatory effects reduces risk factors

Insulin resistance drug with anti-inflammatory effects reduces risk factors

Study shows why thiazolidinediones cause edema and helps understand role of kidneys in hypertension

Study shows why thiazolidinediones cause edema and helps understand role of kidneys in hypertension

Researchers describe emerging strategy for prevention, early treatment of Type 2 diabetes

Researchers describe emerging strategy for prevention, early treatment of Type 2 diabetes

Keeping fit lowers C-Reactive protein in people with metabolic syndrome

Keeping fit lowers C-Reactive protein in people with metabolic syndrome

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.